Details for Patent: 11,020,363
✉ Email this page to a colleague
Which drugs does patent 11,020,363 protect, and when does it expire?
Patent 11,020,363 protects EVOMELA and is included in one NDA.
This patent has twenty-two patent family members in fourteen countries.
Summary for Patent: 11,020,363
Title: | Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same |
Abstract: | The present disclosure is directed to pharmaceutical compositions comprising a nitrogen mustard and a cyclodextrin derivative, and methods of making and using the same. |
Inventor(s): | Pipkin; James D. (Lawrence, KS), Machatha; Stephen G. (Overland Park, KS) |
Assignee: | Cydex Pharmaceuticals, Inc. (Lenexa, KS) |
Application Number: | 14/229,523 |
Patent Claim Types: see list of patent claims | Composition; Formulation; |
Drugs Protected by US Patent 11,020,363
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acrotech Biopharma | EVOMELA | melphalan hydrochloride | POWDER;INTRAVENOUS | 207155-001 | Mar 10, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,020,363
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2010253905 | ⤷ Try a Trial | |||
Brazil | PI1012301 | ⤷ Try a Trial | |||
Canada | 2763365 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |